Alleged violations of the Code during an event
If, as per your judgment, actions were taken during the conduct of a scientific event, with which the participation/sponsorship by a company that has signed the Code of Ethics of the Research-based Pharmaceutical Industry in Bulgaria raises doubts about a potential violation of the provisions of Article 10 of the Code, please report for them.
Connective tissue diseases and inflammatory arthritides - from evidence to practice – for health professionals in rheumatology and young rheumatologists
Last update:
14/10/26
Organized by:
Bulgarian Society of Health Professionals in Rheumatology
Place:
Hilton Sofia Hotel
Start date:
20/11/26
End date:
21/11/26
App. Nr. of HCP:
80
Specialists:
Rheumatology, others
Any practice that might create confusion about the real scientific and educational purpose of scientific events sponsored by industry or to which industry sponsors HCPs should not be tolerated.
ARPharM Final Assessment:
22/10/26
Location and Venue
Hospitality Provided (Directly or Indirectly) to HCP
Other Activities
Accompanying Persons
Scientific Programme Schedule / Structure
Legend
ARPharM’s pre-assessment process is ongoing.
Based on information provided through one of the ways described above (on the date indicated), arrangements would not raise concern with regard to provisions of the ARPharM Article 10 Code of Ethics provisions.
Based on information provided through one of the ways described above (on the date indicated), arrangements may raise concern with regard to provisions of the ARPharM Article 10 Code of Ethics provisions.
It is always recommended to check the rules prevailing under applicable national codes.
EXHIBITIONS: please read carefully the provisions of the ARPharM HCP Code and the additional guidance.

